4.7 Article

X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13.1-q21

期刊

NEUROLOGY
卷 72, 期 3, 页码 246-252

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000339483.86094.a5

关键词

-

向作者/读者索取更多资源

Objective: To clinically characterize and map the gene locus in a three-generation family with an X-linked adult-onset distal hereditary motor neuropathy. Methods: Microsatellite markers spanning the juvenile distal spinal muscular atrophy (DSMAX) locus were genotyped and analyzed using genetic linkage analysis. The promoter, untranslated and coding region of the gap junction beta 1 (GJB1) gene was sequenced. Nine positional candidate genes were screened for disease mutations using high-resolution melt (HRM) analysis. Results: The family showed significant linkage to markers on chromosome Xq13.1-q21. Haplotype construction revealed a disease-associated haplotype between the markers DXS991 and DX5990. Sequence analysis excluded pathogenic changes in the coding and promoter regions of the GJB1 gene. Additional fine mapping in the family refined the DSMAX locus to a 1.44-cM interval between DXS8046 and DXS8114. HRM analysis did not identify disease-associated mutations in the coding region of nine candidate genes. Conclusion: We have identified a family with adult-onset distal hereditary motor neuropathy that refines the locus reported for juvenile distal spinal muscular atrophy (DSMAX) on chromosome Xq13.1-q21. Exclusion of mutations in the coding and regulatory region of the GJB1 gene eliminated the CMTX1 locus as a cause of disease in this family. Nine positional candidate genes in the refined interval underwent mutation analysis and were eliminated as the pathogenic cause of DSMAX in this family. The syndrome in this family may be allelic to the juvenile distal spinal muscular atrophy first reported at this locus. Neurology (R) 2009;72:246-252

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling

Sonia Sanz Munoz, Martin Engel, Rachelle Balez, Dzung Do-Ha, Mauricio Castro Cabral-da-Silva, Damian Hernandez, Tracey Berg, Jennifer A. Fifita, Natalie Grima, Shu Yang, Ian P. Blair, Garth Nicholson, Anthony L. Cook, Alex W. Hewitt, Alice Pebay, Lezanne Ooi

Article Clinical Neurology

Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure

Sindhu Ramchandren, Tong Tong Wu, Richard S. Finkel, Carly E. Siskind, Shawna M. E. Feely, Joshua Burns, Mary M. Reilly, Timothy Estilow Ot, Michael E. Shy

Summary: The study identified 6 domains relevant to quality of life in children with CMT through systematic literature reviews and analysis of generic QOL measures. A total of 60 items corresponding to those domains were developed and underwent rigorous psychometric testing to develop a reliable and valid pediatric CMT-specific quality of life outcome measure.

ANNALS OF NEUROLOGY (2021)

Article Geriatrics & Gerontology

Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis

Sandrine Chan Moi Fat, Emily P. McCann, Kelly L. Williams, Lyndal Henden, Natalie A. Twine, Denis C. Bauer, Roger Pamphlett, Matthew C. Kiernan, Dominic B. Rowe, Garth A. Nicholson, Jennifer A. Fifita, Ian P. Blair

Summary: Mutations in GLT8D1 and ARPP21 are not a common cause of ALS in Australian familial and sporadic cohorts, as no novel mutations were identified in either gene.

NEUROBIOLOGY OF AGING (2021)

Article Neurosciences

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

Ramita Dewan, Ruth Chia, Jinhui Ding, Richard A. Hickman, Thor D. Stein, Yevgeniya Abramzon, Sarah Ahmed, Marya S. Sabir, Makayla K. Portley, Arianna Tucci, Kristina Ibanez, F. N. U. Shankaracharya, Pamela Keagle, Giacomina Rossi, Paola Caroppo, Fabrizio Tagliavini, Maria L. Waldo, Per M. Johansson, Christer F. Nilsson, James B. Rowe, Luisa Benussi, Giuliano Binetti, Roberta Ghidoni, Edwin Jabbari, Coralie Viollet, Jonathan D. Glass, Andrew B. Singleton, Vincenzo Silani, Owen A. Ross, Mina Ryten, Ali Torkamani, Toshiko Tanaka, Luigi Ferrucci, Susan M. Resnick, Stuart Pickering-Brown, Christopher B. Brady, Neil Kowal, John A. Hardy, Vivianna Van Deerlin, Jean Paul Vonsattel, Matthew B. Harms, Huw R. Morris, Raffaele Ferrari, John E. Landers, Adriano Chio, J. Raphael Gibbs, Clifton L. Dalgard, Sonja W. Scholz, Bryan J. Traynor

Summary: Researchers analyzed whole-genome sequence data from 2,442 FTD/ALS patients, 2,599 LBD patients, and 3,158 neurologically healthy subjects, identifying pathogenic HTT gene expansions in a small percentage of FTD/ALS patients but not in the LBD or healthy groups. Postmortem evaluations supported an etiological relationship between HTT repeat expansions and FTD/ALS syndromes, suggesting the importance of genetic screening for HTT repeat expansions in FTD/ALS patients.

NEURON (2021)

Article Clinical Neurology

Loss of function MPZ mutation causes milder CMT1B neuropathy

Paige Howard, Shawna M. E. Feely, Tiffany Grider, Alexa Bacha, Marina Scarlato, Raffaella Fazio, Angelo Quattrini, Michael E. Shy, Stefano C. Previtali

Summary: Mutations in the Myelin Protein Zero (MPZ) gene lead to CMT1B, with toxic gain of function from the mutant protein causing neuropathy, while some patients have haploinsufficiency in the MPZ gene, mainly presenting with sensory neuropathy.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2021)

Article Biology

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma

Alvaro Gonzalez Rajal, Kamila A. Marzec, Rachael A. McCloy, Max Nobis, Venessa Chin, Jordan F. Hastings, Kaitao Lai, Marina Kennerson, William E. Hughes, Vijesh Vaghjiani, Paul Timpson, Jason E. Cain, D. Neil Watkins, David R. Croucher, Andrew Burgess

Summary: The study identified a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure, using RNA sequencing and biosensors to track single-cell fates.
Article Clinical Neurology

Hereditary neuropathies: A pathological perspective

Tiziana Cavallaro, Matteo Tagliapietra, Gian Maria Fabrizi, Yunhong Bai, Michael E. Shy, Jean-Michel Vallat

Summary: Hereditary neuropathies can be caused by mutations in genes expressed by Schwann cells or neurons, and may involve the central nervous system and other organs and tissues, with diagnostic methods revolutionizing due to advances in molecular genetics; skin biopsy has emerged as a minimally invasive method to provide clues to the pathophysiology and molecular pathology of inherited neuropathies.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2021)

Article Genetics & Heredity

Revisiting the pathogenic mechanism of the GJB1 5' UTR c.-103C > T mutation causing CMTX1

Bianca R. Grosz, John Svaren, Gonzalo Perez-Siles, Garth A. Nicholson, Marina L. Kennerson

Summary: This study assessed the IRES activity of the human GJB1 5' UTR and found no significant differences in expression levels between the wild-type UTR and the UTR with the c.-103C > T mutation, suggesting an alternate pathogenic mechanism for this non-coding mutation.

NEUROGENETICS (2021)

Editorial Material Clinical Neurology

Featured Cover

Tiziana Cavallaro, Matteo Tagliapietra, Gian Maria Fabrizi, Yunhong Bai, Michael E. Shy, Jean-Michel Vallat

Summary: The cover image is based on the Special Issue HEREDITARY NEUROPATHIES: A PATHOLOGICAL PERSPECTIVE by Tiziana Cavallaro et al., focusing on hereditary neuropathies from a pathological perspective.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2021)

Review Clinical Neurology

Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints

Mary M. Reilly, David N. Herrmann, Davide Pareyson, Steven S. Scherer, Richard S. Finkel, Stephan Zuechner, Joshua Burns, Michael E. Shy

Summary: Heritable neurological disorders provide insights into disease mechanisms, facilitating the development of novel therapeutic approaches. The challenges of measuring disease progression in rare and slowly progressive neurogenetic diseases are addressed through the development of clinical outcome assessments and disease biomarkers in inherited peripheral neuropathies. It is proposed that carefully developed biomarkers from imaging, plasma, or skin can predict meaningful progression in functional and patient-reported outcome assessments, enabling feasible clinical trials within a shorter duration for these rare and ultra-rare disorders.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure

Tong Tong Wu, Richard S. S. Finkel, Carly E. E. Siskind, Shawna M. E. Feely, Joshua Burns, Mary M. M. Reilly, Francesco Muntoni, Timothy Estilow, Michael E. E. Shy, Sindhu Ramchandren

Summary: This study developed and validated the parent-proxy version of the pCMT-QOL outcome measure for children aged 8 to 18 with CMT, which is a reliable and valid measure of health-related QOL.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2023)

Article Clinical Neurology

Validation of the parent-proxy version of the pediatric Charcot-Marie-Tooth disease quality of life instrument for children aged 0-7 years

Tong Tong Wu, Richard Finkel, Carly E. Siskind, Shawna M. E. Feely, Joshua Burns, Mary M. Reilly, Francesco Muntoni, Evelin Milev, Timothy Estilow, Michael E. Shy, Sindhu Ramchandren

Summary: The objective of this study was to evaluate the parent-proxy version of the pediatric Charcot Marie Tooth specific quality of life (pCMT-QOL) outcome instrument for children aged 7 or younger with CMT. The parent-proxy version of the pCMT-QOL outcome measure, known as the pCMT-QOL (0-7 years parent-proxy), was validated as a valid and sensitive proxy measure of health-related quality of life for children aged 0-7 years with CMT.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2023)

Article Clinical Neurology

Homomeric interactions of the MPZ Ig domain and their relation to Charcot-Marie-Tooth disease

Christopher P. Ptak, Tabitha A. Peterson, Jesse B. Hopkins, Christopher A. Ahern, Michael E. Shy, Robert C. Piper

Summary: Mutations in MPZ can cause various neurological disorders, and the study focuses on understanding how MPZ functions and forms oligomeric assemblies.
Article Clinical Neurology

Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance

Matthew Silsby, Con Yiannikas, Alessandro F. Fois, Marina L. Kennerson, Matthew C. Kiernan, Victor S. C. Fung, Steve Vucic

Summary: Neuropathic tremor is a common clinical feature in CMT1A, with distinct characteristics compared to essential tremor. Upper limb tremors were postural and kinetic, while lower limb tremors were postural and orthostatic. The frequency of upper limb tremors varied along the limb, with a lower frequency distally and a higher frequency proximally. Lower limb tremors had a consistent frequency and were unaffected by fatigue. Postural lower limb tremor was associated with imbalance.

JOURNAL OF NEUROLOGY (2023)

Article Biotechnology & Applied Microbiology

Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders

Marta F. Nabais, Simon M. Laws, Tian Lin, Costanza L. Vallerga, Nicola J. Armstrong, Ian P. Blair, John B. Kwok, Karen A. Mather, George D. Mellick, Perminder S. Sachdev, Leanne Wallace, Anjali K. Henders, Ramona A. J. Zwamborn, Paul J. Hop, Katie Lunnon, Ehsan Pishva, Janou A. Y. Roubroeks, Hilkka Soininen, Magda Tsolaki, Patrizia Mecocci, Simon Lovestone, Iwona Kloszewska, Bruno Vellas, Sarah Furlong, Fleur C. Garton, Robert D. Henderson, Susan Mathers, Pamela A. McCombe, Merrilee Needham, Shyuan T. Ngo, Garth Nicholson, Roger Pamphlett, Dominic B. Rowe, Frederik J. Steyn, Kelly L. Williams, Tim J. Anderson, Steven R. Bentley, John Dalrymple-Alford, Javed Fowder, Jacob Gratten, Glenda Halliday, Ian B. Hickie, Martin Kennedy, Simon J. G. Lewis, Grant W. Montgomery, John Pearson, Toni L. Pitcher, Peter Silburn, Futao Zhang, Peter M. Visscher, Jian Yang, Anna J. Stevenson, Robert F. Hillary, Riccardo E. Marioni, Sarah E. Harris, Ian J. Deary, Ashley R. Jones, Aleksey Shatunov, Alfredo Iacoangeli, Wouter van Rheenen, Leonard H. van den Berg, Pamela J. Shaw, Cristopher E. Shaw, Karen E. Morrison, Ammar Al-Chalabi, Jan H. Veldink, Eilis Hannon, Jonathan Mill, Naomi R. Wray, Allan F. McRae

Summary: This study identified shared differentially methylated positions in whole blood between neurodegenerative disorders, indicating shared pathogenic mechanisms. Immune abnormalities caused by different neurodegenerative diseases may be interrelated to some extent.

GENOME BIOLOGY (2021)

暂无数据